Clinical Trials Directory

Trials / Unknown

UnknownNCT02458755

Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis

Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis - High-Resolution Magnetic Resonance Imaging Study (STAMINA-MRI Study)

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Purpose: Intracranial atherosclerosis is a common condition in Korean population consisting over 25% of ischemic stroke etiology. American Stroke Association and Korean Stroke Society recommend antiplatelet and statin for the treatment of intracranial atherosclerosis. Besides lowering blood cholesterol levels statin also stabilize atherosclerotic plaque and eventually lower the risk of ischemic stroke. However, little evidence resides on the effect of statin treatment on intracranial atherosclerosis. Recent advance in high-tesla magnetic resonance imaging enables direct imaging of intracranial atherosclerotic plaque and further assessment of treatment efficacy of statin in stabilization of intracranial atherosclerotic plaque became possible.

Conditions

Interventions

TypeNameDescription
DRUGHigh-dose statin: Atorvastatin 40mg or Rosuvastatin 20mgAtorvastatin 40mg or Rosuvastatin 20mg

Timeline

Start date
2012-02-01
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2015-06-01
Last updated
2017-04-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02458755. Inclusion in this directory is not an endorsement.